Abstract:Biological mechanisms to promote dietary balance remain unclear. Fibroblast growth factor 21 (FGF21) has been suggested to contribute to such potential regulation considering that FGF21 1) is genetically associated with carbohydrate/sugar and protein intake in opposite directions, 2) is secreted after sugar ingestion and protein restriction, and 3) pharmacologically reduces sugar and increases protein intake in rodents. To gain insight of the nature of this potential regulation, we aimed to study macronutrient interactions in the secretory regulation of FGF21 in healthy humans. We conducted a randomized, double-blinded, crossover meal study (NCT05061485), wherein healthy volunteers consumed a sucrose drink, a sucrose + protein drink, and a sucrose + fat drink (matched sucrose content), and compared postprandial FGF21 responses between the three macronutrient combinations. Protein suppressed the sucrose-induced FGF21 secretion [incremental area under the curve (iAUC) for sucrose 484 ± 127 vs. sucrose + protein -35 ± 49 pg/mL × h, P < 0.001]. The same could not be demonstrated for fat (iAUC 319 ± 102 pg/mL × h, P = 203 for sucrose + fat vs. sucrose). We found no indications that regulators of glycemic homeostasis could explain this effect. This indicates that FGF21 responds to disproportionate intake of sucrose relative to protein acutely within a meal, and that protein outweighs sucrose in FGF21 regulation. Together with previous findings, our results suggests that FGF21 might act to promote macronutrient balance and sufficient protein intake.NEW & NOTEWORTHY Here we test the interactions between sugar, protein, and fat in human FGF21 regulation and demonstrate that protein, but not fat, suppresses sugar-induced FGF21 secretion. This indicates that protein outweighs the effects of sugar in the secretory regulation of FGF21, and could suggest that the nutrient-specific appetite-regulatory actions of FGF21 might prioritize ensuring sufficient protein intake over limiting sugar intake.

FGF21 as a mediator of adaptive changes in food intake and macronutrient preference in response to protein restriction

FGF21 acts in the brain to drive macronutrient-specific changes in behavioral motivation and brain reward signaling

Gut microbiota mediate the FGF21 adaptive stress response to chronic dietary protein-restriction in mice

Persistent Behavioral and Physiological Effects of Dietary Protein Restriction

Fibroblast Growth Factor 21 Facilitates the Homeostatic Control of Feeding Behavior

FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice

Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine

Protein Restriction in Metabolic Health: Lessons from Rodent Models

The Nuanced Metabolic Functions of Endogenous FGF21 Depend on the Nature of the Stimulus, Tissue Source, and Experimental Model

Meal sugar-protein balance determines postprandial FGF21 response in humans

FGF21 mediating the Sex-dependent Response to Dietary Macronutrients

Metabolic Messengers: FGF21

Low Protein Diets and Energy Balance: Mechanisms of Action on Energy Intake and Expenditure

FGF21 prevents low protein diet-induced renal inflammation in aged mice.

Distinct genetic signals at the FGF21 locus complicate studies of FGF21's role in diet regulation using human cohort data

Diet pattern determines circulating FGF21 levels while distinct FGF21 variants influence diet pattern and FGF21 levels

Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives

FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

Experimental evolution of metabolism under nutrient restriction: enhanced amino acid catabolism and a key role of branched-chain amino acids

The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic